VDAC1, mitochondrial dysfunction, and Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pharmacological Research

• Publication date

  2018-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.phrs.2018.03.010PMID 29551631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RNA on the brain: emerging layers of post‐transcriptional regulation in cerebral cortex development

  2018cited by this paper
• Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics

  2017cited by this paper
• Novel insights into role of miR‐320a‐VDAC1 axis in astrocyte‐mediated neuronal damage in neuroAIDS

  2017cited by this paper
• Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets

  2017cited by this paper
• Impaired peripheral glucose homeostasis and Alzheimer's disease

  2017cited by this paper
• Suppression of microRNA-9-5p rescues learning and memory in chronic cerebral hypoperfusion rats model

  2017cited by this paper
• Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma

  2017cited by this paper
• The Voltage-Dependent Anion Channels (VDAC) of Mycobacterium avium phagosome are associated with bacterial survival and lipid export in macrophages

  2017cited by this paper
• Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate

  2017cited by this paper
• Bidirectional interactions between diabetes and Alzheimer's disease.

  2017cited by this paper
• VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress

  2017cited by this paper
• Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.

  2017cited by this paper
• A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis *

  2016cited by this paper
• MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression*

  2016cited by this paper
• MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis

  2016cited by this paper
• miR-29a differentially regulates cell survival in astrocytes from cornu ammonis 1 and dentate gyrus by targeting VDAC1.

  2016cited by this paper
• lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy

  2016cited by this paper
• Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy

  2016cited by this paper
• The amyloid hypothesis of Alzheimer's disease at 25 years

  2016cited by this paper
• P1‐146: Chlamydia Pneumoniae‐Infected Astrocytes Alter Their Expression of Adam10, Bace1, and Presenilin‐1 Proteases

  2016cited by this paper
• Diabetes and Alzheimer's disease crosstalk.

  2016cited by this paper
• Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction*

  2016cited by this paper
• Biological and biophysics aspects of metformin-induced effects: cortex mitochondrial dysfunction and promotion of toxic amyloid pre-fibrillar aggregates

  2016cited by this paper
• 2016 Alzheimer's disease facts and figures

  2016cited by this paper
• Nuclear but not mitochondrial‐encoded oxidative phosphorylation genes are altered in aging, mild cognitive impairment, and Alzheimer's disease

  2016cited by this paper
• VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.

  2016cited by this paper
• A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease

  2015cited by this paper
• The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy*

  2015cited by this paper
• Spatial cognitive deficits in an animal model of Wernicke-Korsakoff syndrome are related to changes in thalamic VDAC protein concentrations.

  2015cited by this paper
• Human brain proteins showing neuron‐specific interactions with γ‐secretase

  2015cited by this paper
• The mitochondrial voltage-dependent anion channel 1 in tumor cells.

  2015cited by this paper
• Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

  2015cited by this paper
• CREB1-driven expression of miR-320a promotes mitophagy by down-regulating VDAC1 expression during serum starvation in cervical cancer cells

  2015cited by this paper
• A New Fungal Diterpene Induces VDAC1-dependent Apoptosis in Bax/Bak-deficient Cells*

  2015cited by this paper
• Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.

  2014cited by this paper
• Alzheimer's disease research and development: a call for a new research roadmap

  2014cited by this paper
• Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

  2014cited by this paper
• Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer's Disease

  2014cited by this paper
• New perspectives on the role of tau in Alzheimer's disease. Implications for therapy.

  2014cited by this paper
• Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review

  2014cited by this paper
• Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice

  2014cited by this paper
• A brief overview of amyloids and Alzheimer's disease

  2014cited by this paper
• Signaling pathway cross talk in Alzheimer’s disease

  2014cited by this paper
• Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.

  2014cited by this paper
• Mitochondrial import and degradation of amyloid-β peptide.

  2014cited by this paper
• Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.

  2014cited by this paper
• Apoptosis and Oxidative Stress in Neurodegenerative Diseases

  2014cited by this paper
• Reduced VDAC1 Protects Against Alzheimer's Disease, Mitochondria, and Synaptic Deficiencies

  2013cited by this paper
• Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage.

  2013cited by this paper
• Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease

  2013cited by this paper
• Proteomic identification of the candidate target proteins of 15‐deoxy‐delta12,14‐prostaglandin J2

  2013cited by this paper
• Evidence for impaired amyloid β clearance in Alzheimer's disease

  2013cited by this paper
• Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?

  2013cited by this paper
• Insulin dysfunction and Tau pathology

  2013cited by this paper
• A review on cholinesterase inhibitors for Alzheimer’s disease

  2013cited by this paper
• VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia

  2013cited by this paper
• Mitochondrial Alterations near Amyloid Plaques in an Alzheimer's Disease Mouse Model

  2013cited by this paper
• Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.

  2013cited by this paper
• The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.

  2013cited by this paper
• New findings concerning vertebrate porin II--on the relevance of glycine motifs of type-1 VDAC.

  2013cited by this paper
• Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.

  2012cited by this paper
• Structure-based analysis of VDAC1: N-terminus location, translocation, channel gating and association with anti-apoptotic proteins.

  2012cited by this paper
• VDAC: old protein with new roles in diabetes.

  2012cited by this paper
• Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.

  2012cited by this paper
• Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.

  2012cited by this paper
• Insights into Mitochondrial Dysfunction: Aging, Amyloid-β, and Tau–A Deleterious Trio

  2012cited by this paper
• Mediation of the Antiapoptotic Activity of Bcl-xL Protein upon Interaction with VDAC1 Protein*

  2012cited by this paper
• Mitochondria and Cell Bioenergetics: Increasingly Recognized Components and a Possible Etiologic Cause of Alzheimer's Disease

  2012cited by this paper
• Alzheimer disease controls cancer - concerning the apoptogenic interaction of cell membrane-standing type-1 VDAC and amyloid peptides via GxxxG motifs.

  2012cited by this paper
• Mitochondrial VDAC1: function in cell life and death and a target for cancer therapy.

  2012cited by this paper
• Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.

  2012cited by this paper
• Truncated tau and Aβ cooperatively impair mitochondria in primary neurons.

  2012cited by this paper
• Identification of Novel γ-Secretase-associated Proteins in Detergent-resistant Membranes from Brain*

  2012cited by this paper
• An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.

  2012cited by this paper
• Plasmalemmal VDAC controversies and maxi-anion channel puzzle.

  2012cited by this paper
• VDAC1: from structure to cancer therapy

  2012cited by this paper
• The role of lipids in VDAC oligomerization.

  2012cited by this paper
• Identification of Novel Targets for miR-29a Using miRNA Proteomics

  2012cited by this paper
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

  2012cited by this paper
• Mitochondria in neurodegeneration.

  2012cited by this paper
• Inverse association between cancer and Alzheimer’s disease: results from the Framingham Heart Study

  2012cited by this paper
• Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

  2012cited by this paper
• Enhanced Expression of the Voltage-Dependent Anion Channel 1 (VDAC1) in Alzheimer's Disease Transgenic Mice: An Insight into the Pathogenic Effects of Amyloid-β

  2011cited by this paper
• Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

  2011cited by this paper
• Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.

  2011cited by this paper
• The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

  2011cited by this paper
• Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.

  2011cited by this paper
• Apoptogenic interactions of plasmalemmal type-1 VDAC and Aβ peptides via GxxxG motifs induce Alzheimer's disease – a basic model of apoptosis?*

  2011cited by this paper
• Voltage‐dependent anion channel as a resident protein of lipid rafts: post‐transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer’s disease

  2011cited by this paper
• Systems neuroscience: The stress of dieting

  2011cited by this paper
• Structure-based Analysis of VDAC1 Protein

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Molecular biology of Bax and Bak activation and action.

  2011cited by this paper
• Protein oligomerization mediated by the transmembrane carboxyl terminal domain of Bcl-XL

  2011cited by this paper
• Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology.

  2010cited by this paper
• Voltage‐dependent anion‐selective channel (VDAC) in the plasma membrane

  2010cited by this paper
• A Mitocentric View of Alzheimer's Disease Suggests Multi-Faceted Treatments

  2010cited by this paper
• [The role of the voltage-dependent anion channels in the outer membrane of mitochondria in the regulation of cellular metabolism].

  2010cited by this paper
• Oligomerization of the Mitochondrial Protein Voltage-Dependent Anion Channel Is Coupled to the Induction of Apoptosis

  2010cited by this paper
• Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes

  2010cited by this paper

• Brain-targeted delivery of siRNA via non-viral delivery systems, the therapeutic strategy for Alzheimer's disease—Unveiling challenges and prospects

  2026cites this paper
• Advances in fluorescent probe design and imaging applications for Alzheimer's disease biomarker

  2026cites this paper
• The pivotal role of mitochondria in the pathogenesis and treatment of liver failure: a comprehensive review.

  2026cites this paper
• Identification of CTHRC1 as a novel candidate for neurodevelopmental disorders

  2026cites this paper
• Multi-target intervention mechanisms and prospects of the traditional Chinese medicine Scutellaria baicalensis georgi in Alzheimer’s disease

  2026cites this paper
• Selective antagonism of adenosine A2A receptor reduces hypobaric hypoxia-induced neuroinflammation by inhibiting cGAS-STING pathway

  2026cites this paper
• Targeting the Nrf2/HO-1 aixs: a therapeutic strategy against regulated cell death in Alzheimer's disease.

  2026cites this paper
• VDAC1 oligomerization activates PANoptosis via mtDNA-STING axis in age-related macular degeneration

  2026cites this paper
• Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer’s disease

  2025influential citation
• The necroptosis-related lncRNA ENSG00000253385.1 promotes the progression of esophageal squamous cell carcinoma by targeting the miR-16-2-3p/VDAC1 axis

  2025cites this paper
• Enhanced Alzheimer’s Disease Prediction Through Integration of Protein-Protein Interaction Data and Meta-Learning

  2025cites this paper
• Biomarker Identification for Alzheimer’s Disease Using a Multi-Filter Gene Selection Approach

  2025cites this paper
• Liquiritigenin Alleviates Inflammation and Mitochondrial Dysfunction in Acute Pancreatitis via ERβ-VDAC1 Signaling.

  2025cites this paper
• Anxa10 and neuropathic pain: Insights into dysregulation of endoplasmic reticulum-mitochondria contact tethering complex and therapeutic potential.

  2025cites this paper
• Mitochondrial Damage and Autophagy Dysregulation in Alzheimer’s Disease: Mechanisms and Therapeutic Opportunities

  2025cites this paper
• Mitochondria‐Associated Membranes: A Key Point of Neurodegenerative Diseases

  2025cites this paper
• Modulation of mitochondrial dysfunction: Mechanisms and strategies for the use of natural products to treat stroke.

  2025cites this paper
• Structural basis of apoptosis induction by the mitochondrial voltage-dependent anion channel

  2025cites this paper
• Acupuncture treatment of vascular cognitive impairment through peripheral nerve stimulation pathway: a scoping review

  2025cites this paper
• Nanotechnology in Parkinson’s Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes

  2025cites this paper
• Multi-target neuroprotection by dl-PHPB in APP/PS1 mice: a proteomic analysis

  2025cites this paper
• Potential Role of Membrane Contact Sites in the Dysregulation of the Crosstalk Between Mitochondria and Lysosomes in Alzheimer’s Disease

  2025cites this paper
• Pleiotropic regulatory mechanisms and targeted therapeutic prospects of Galectin-3 in aging-related diseases

  2025cites this paper
• The Janus face of CaMKII: from memory consolidation to neurotoxic switch in Alzheimer’s disease

  2025influential citation
• Unraveling the mystery of citrate transporters in Alzheimer's disease: An updated review.

  2025cites this paper
• The Advancements of Marine Natural Products in the Treatment of Alzheimer’s Disease: A Study Based on Cell and Animal Experiments

  2025cites this paper
• A review of the pathogenesis of mitochondria in breast cancer and progress of targeting mitochondria for breast cancer treatment

  2025cites this paper
• Mitochondrial Dysfunction in Alzheimer's Disease.

  2025cites this paper
• The role of mitochondria-associated ER membranes in disease pathology: protein complex and therapeutic targets

  2025cites this paper
• Stress-related neurodegenerative diseases: Molecular mechanisms implicated in neurodegeneration and therapeutic strategies.

  2025cites this paper
• Exploring the Role of Mitochondria in Alzheimer with Network Pharmacology: A Bioinformatics Analysis

  2025cites this paper
• Ganoderma lucidum polysaccharides target the gut-brain axis: Unveiling a novel mechanism for ameliorating aging-induced cognitive impairment and oxidative stress.

  2025cites this paper
• Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer's disease.

  2025cites this paper
• Therapeutic efficacy of rehmannioside A on 5×FAD mice in Alzheimer’s disease

  2025cites this paper
• Stabilization of VDAC1 by USP10 facilitates radioresistance and metastasis in nasopharyngeal carcinoma via MTOR-dependent autophagy pathway: an experimental study.

  2025cites this paper
• Intranasal insulin administration affecting perioperative neurocognitive dysfunction by regulating calcium transport protein complex IP3R/GRP75/VDAC1 on MAMs.

  2025cites this paper
• Targeting intracellular tau with a gene-encoded single-chain antibody promotes neuronal homeostasis and ameliorates tau pathology

  2025cites this paper
• Is the Voltage-Dependent Anion Channel a Major Player in Neurodegenerative Diseases?

  2025cites this paper
• Nitric oxide induces apoptosis of human primary melanocytes by regulating calcium homeostasis via VDAC1

  2025cites this paper
• Innovations in Alzheimer’s disease diagnostic technologies: clinical prospects of novel biomarkers, multimodal integration, and non-invasive detection

  2025cites this paper
• Calcium signaling hypothesis: A non-negligible pathogenesis in Alzheimer’s disease

  2025cites this paper
• Mitochondria Transfer in Mesenchymal Stem Cells: Unraveling the Mechanism and Therapeutic Potential

  2025cites this paper
• Temporal Interactome Mapping of Human Tau in Drosophila Reveals Progressive Mitochondrial Engagement and Porin/VDAC1-Dependent Modulation of Toxicity

  2025cites this paper
• PA1b-like peptides alleviate mitochondrial dysfunction induced by glucose toxicity through interaction with VDAC1 in β-cells.

  2025cites this paper
• A calmodulin-derived peptide TI-16 inhibits Alzheimer's disease progression by decreasing -Aβ burden and restoring calcium dyshomeostasis.

  2025cites this paper
• A potential therapeutic approach for ulcerative colitis: targeted regulation of mitochondrial dynamics and mitophagy through phytochemicals

  2025cites this paper
• Visual Analysis of Research Hotspots and Trends on Mitochondria-Associated Membranes in the Past 20 Years—Focused on Neurodegenerative Diseases

  2025cites this paper
• VDAC1 Inhibition Mitigates Inflammatory Status and Oxidative Stress in Epileptic Mice Treated with the Ketogenic Diet

  2025cites this paper
• RfeA from Streptococcus suis serotype 2 triggers NLRP3/Caspase-1-dependent pyroptosis leading to blood–brain barrier disruption

  2025cites this paper
• VDAC1-enriched apoptotic extracellular vesicles emerge as an autophagy activator orchestrating PDLSC-based bone regeneration

  2024cites this paper
• Targeting STAT3 signaling pathway in the treatment of Alzheimer's disease with compounds from natural products.

  2024cites this paper
• The role and mechanism of VDAC1 in type 2 diabetes: An underestimated target of environmental pollutants.

  2024cites this paper
• Glucose 6 phosphate dehydrogenase overexpression rescues the loss of cognition in the double transgenic APP/PS1 mouse model of Alzheimer’s disease

  2024cites this paper
• Neurons Structure and Cytokine Expression after Lithium Carbonate Treatment on Melanoma Mice Model

  2024cites this paper
• ROCK Inhibitor Fasudil Attenuates Neuroinflammation and Associated Metabolic Dysregulation in the Tau Transgenic Mouse Model of Alzheimer's Disease.

  2024cites this paper
• Neuroprotective comparisons and bioactive profiles of green tea and black tea: in vitro cellular experiments, metabolomics, and network pharmacology analysis

  2024cites this paper
• Effect of VBIT-4 on the functional activity of isolated mitochondria and cell viability.

  2024cites this paper
• Hsa_circ_0064636 regulates voltage dependent anion channel 1/ubiquitination factor E4A through miR‑326/miR‑503‑5 in osteosarcoma

  2024cites this paper
• The Role of Protein S-Nitrosylation in Mitochondrial Quality Control in Central Nervous System Diseases

  2024cites this paper
• L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review

  2024cites this paper
• Neuroenergetic alterations in neurodegenerative diseases: A systematic review and meta-analysis of in vivo31P-MRS studies.

  2024cites this paper
• Metformin in COVID-19: a magical role beyond the hyperglycemia

  2024cites this paper
• Electropositive Citric Acid-Polyethyleneimine Carbon Dots Carrying the PINK1 Gene Regulate ATP-Related Metabolic Dysfunction in APP/PS1-N2a Cells

  2024cites this paper
• Aerobic Exercise Ameliorates Cognitive Disorder and Declined Oxidative Stress via Modulating the Nrf2 Signaling Pathway in d-galactose Induced Aging Mouse Model

  2024cites this paper
• Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.

  2024cites this paper
• Alleviating Neurodegenerative Diseases Associated with Mitochondrial Defects by Therapeutic Biomolecules.

  2024cites this paper
• Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics

  2024cites this paper
• Mitochondrial Alterations in Alzheimer’s Disease: Insight from the 5xFAD Mouse Model

  2024cites this paper
• VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration

  2024cites this paper
• ER-organelle contacts: A signaling hub for neurological diseases.

  2024cites this paper
• The association between methylmalonic acid, a biomarker of mitochondrial dysfunction, and cause-specific mortality in Alzheimer's disease and Parkinson's disease

  2024cites this paper
• Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current insights and future directions.

  2024cites this paper
• Reduced 17β-estradiol following ovariectomy induces mitochondrial dysfunction and degradation of synaptic proteins in the entorhinal cortex.

  2024cites this paper
• 3-Monochloropropane-1,2-diol esters induce HepG2 cells necroptosis via CTSB/TFAM/ROS pathway.

  2024cites this paper
• Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease

  2024cites this paper
• Age-related hearing loss: possible associations with Alzheimer’s disease

  2024cites this paper
• Novel cuproptosis metabolism-related molecular clusters and diagnostic signature for Alzheimer’s disease

  2024cites this paper
• The role of rapamycin in the PINK1/Parkin signaling pathway in mitophagy in podocytes

  2024cites this paper
• Valosin-Containing Protein: A Potential Therapeutic Target for Cardiovascular Diseases.

  2024cites this paper
• Neuronal Protection by Ha-RAS-GTPase Signaling through Selective Downregulation of Plasmalemmal Voltage-Dependent Anion Channel-1

  2024cites this paper
• Decoding Cancer through Silencing the Mitochondrial Gatekeeper VDAC1

  2024cites this paper
• Parallel Computing-Based Genome-Wide Epistasis Analysis of CSF Total Tau in ADNI Cohort

  2024cites this paper
• Progress of Mitochondrial Function Regulation in Cardiac Regeneration

  2024cites this paper
• 6‴-Feruloylspinosin Alleviates Aβ-Induced Toxicity by Modulating Relevant Neurotransmitter and the AMPK/mTOR Signaling Pathway.

  2024cites this paper
• Functional analysis of two SLC9A6 frameshift variants in lymphoblastoid cells from patients with Christianson syndrome

  2023cites this paper
• Promotion of mitochondrial fragmentation suppresses the formation of mitochondrial spherical compartmentation in PINK1B9Drosophila melanogaster.

  2023cites this paper
• TMBIM6 prevents VDAC1 multimerization and improves mitochondrial quality control to reduce sepsis-related myocardial injury.

  2023cites this paper
• Increased interaction between endoplasmic reticulum and mitochondria following sleep deprivation

  2023cites this paper
• Mitochondrial damage-induced abnormal glucose metabolism with ageing in the hippocampus of APP/PS1 mice

  2023cites this paper
• SIRT3 ameliorates diabetes-associated cognitive dysfunction via regulating mitochondria-associated ER membranes

  2023cites this paper
• Upregulation of the ERRγ–VDAC1 axis underlies the molecular pathogenesis of pancreatitis

  2023cites this paper
• Mitochondria in Aging and Alzheimer’s Disease: Focus on Mitophagy

  2023cites this paper
• Trends of mitochondrial changes in AD: a bibliometric study

  2023cites this paper
• The roles of natural triterpenoid saponins against Alzheimer's disease

  2023cites this paper
• Mitochondria Have Made a Long Evolutionary Path from Ancient Bacteria Immigrants within Eukaryotic Cells to Essential Cellular Hosts and Key Players in Human Health and Disease

  2023cites this paper
• Construction and evaluation of Alzheimer’s disease diagnostic prediction model based on genes involved in mitophagy

  2023cites this paper
• Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic Extract

  2023cites this paper
• Structural basis of bioenergetic protein complexes in Alzheimer's disease pathogenesis.

  2023cites this paper
• Octadecaneuropeptide Ameliorates Cognitive Impairments Through Inhibiting Oxidative Stress in Alzheimer’s Disease Models

  2023cites this paper
• Effect of Human Milk Oligosaccharides on Learning and Memory in Mice with Alzheimer's Disease.

  2023cites this paper